News

WHO Declares Monkeypox Spread a Global Health Emergency

July 25, 2022

WHO has determined that monkeypox constitutes a public health emergency of international concern.

Merck and Orion Announce Global Collaboration for Oncology Drug

July 25, 2022

Merck, known as MSD outside the United States and Canada, and Orion Corporation are collaborating to develop and commercialize a treatment for metastatic castration-resistant prostate cancer.

EMA Recommends Eleven New Medicines

July 25, 2022

The agency’s human medicines committee recommended drugs to treat breast cancer, lupus nephritis, type 2 diabetes and more.

EMA Endorses Statement on International Collaboration of Real-World Evidence

July 25, 2022

A joint statement calling for international collaboration on the creation and use of real-world evidence has been published by the International Coalition of Medicines Regulatory Authorities.

Hospira Issues Voluntary Recall for One Lot of Propofol Injectable Emulsion, USP

July 20, 2022

Hospira has issued a voluntary nationwide recall for one lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), due to the potential presence of visible particulate.

I Saw the Future of Global Pharmaceutical Production in India

July 19, 2022

Guest contributor Frederic Kahn discusses the state of the Indian pharmaceutical manufacturing industry.

TFF Pharmaceuticals Expands R&D Operations with New Facility

July 19, 2022

TFF Pharmaceuticals is expanding its R&D operations with a new facility in Austin, Texas.

PerkinElmer Introduces New Cytometry Management Service

July 19, 2022

The PerkinElmer Flow Cytometry Instrument Concierge Services will provide biopharmaceutical labs with expert, on-site flow cytometry specialists.

Cytiva Acquires Chromatography Resins Manufacturing Facility in Muskegon, Michigan

July 19, 2022

Cytiva has acquired a new chromatography resins manufacturing site in the United States as part of its $1.5 billion capacity expansion investment.

Health Canada Authorizes Moderna’s COVID-19 Vaccine in Young Children

July 18, 2022

Health Canada has authorized Moderna’s COVID-19 vaccine for use in young children aged six months to five years.